Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT03050554
Title Stereotactic Body Radiation Therapy (SBRT) Combined With Avelumab (Anti-PD-L1) for Management of Early Stage Non-Small Cell Lung Cancer (NSCLC)
Recruitment Terminated
Gender both
Phase Phase Ib/II
Variant Requirements No
Sponsors Andrew Sharabi
Indications

lung non-small cell carcinoma

Therapies

Avelumab

Age Groups: adult | senior
Covered Countries USA


No variant requirements are available.